RemeGen Co

RemeGen Co Net Debt per Share

The Net Debt per Share of RemeGen Co (688331.SS) as of Oct 26, 2026 is -1.77 CNY. In the previous year, Net Debt per Share was 3.55 CNY — a change of -149.86% (lower).

Net Debt per Share

-1.77CNY

YoY

-149.86%

Last updated:

Net Debt per Share of RemeGen Co is 2025 -1.77 CNY. Net Debt per Share of RemeGen Co was 2024 3.55 CNY. It decreases by -149.86% lower compared to the previous year.

The RemeGen Co Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2018
1.59 CNY
Jan 1, 2019
1.15 CNY
Jan 1, 2020
-4.78 CNY
Jan 1, 2021
-3.08 CNY
Jan 1, 2022
-3.54 CNY
Jan 1, 2023
1.02 CNY
Jan 1, 2024
3.55 CNY
Jan 1, 2025
-1.77 CNY
The RemeGen Co Net Debt per Share history
YEARNet Debt per ShareYoY
-1.77CNY-149.86%
3.55CNY+246.88%
1.02CNY-128.93%
-3.54CNY+15.12%
-3.08CNY-35.66%
-4.78CNY-517.37%
1.15CNY-28.11%
1.59CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

RemeGen Co Stock analysis

What does RemeGen Co do? RemeGen Co Ltd generates revenue by researching, developing, and manufacturing innovative biopharmaceuticals, specifically focusing on therapeutic antibody drugs. The company's product portfolio includes tetacept (RC18), veldicitumab (RC48), and a dual-target fusion protein (RC28). These products are designed to treat major diseases such as oncology, autoimmune diseases, and ophthalmology. The firm operates primarily in the domestic market within China, where it commercializes its discoveries. Its business model relies on the development of various antibody types, including antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. This focus allows the company to address significant medical needs through its specialized therapeutic offerings. RemeGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RemeGen Co stock

Net Debt per Share of RemeGen Co is -1.77 CNY in 2025.

Net Debt per Share of RemeGen Co changed from 3.55 CNY to -1.77 CNY, representing a -149.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share RemeGen Co since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Other — RemeGen Co

Shares OutstandingSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — RemeGen Co